Parkside Financial Bank & Trust’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.03K Sell
55
-30
-35% -$4.27K ﹤0.01% 1764
2025
Q4
$14.1K Buy
85
+19
+29% +$3.18K ﹤0.01% 1425
2025
Q3
$12.9K Buy
66
+12
+22% +$1.97K ﹤0.01% 1420
2025
Q2
$4.88K Buy
54
+48
+800% +$3.79K ﹤0.01% 1711
2025
Q1
$359 Sell
6
-42
-88% -$3.88K ﹤0.01% 2589
2024
Q4
$6.36K Buy
+48
New +$4.5K ﹤0.01% 1407

Other funds holding ALAB

Parkside Financial Bank & Trust's ALAB Position: Q1 2026 in Review

Parkside Financial Bank & Trust reduced its Astera Labs (ALAB) stake by 35% in Q1 2026, selling an estimated $4.27K and leaving 55 shares worth $6.03K. The position accounts for ﹤0.01% of the portfolio, ranked #1764.

Parkside Financial Bank & Trust first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $14.1K in Q4 2025. 706 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Parkside Financial Bank & Trust held 55 shares of Astera Labs worth $6.03K as of Q1 2026.
  • Parkside Financial Bank & Trust sold 30 Astera Labs shares in Q1 2026, an estimated $4.27K.
  • Astera Labs made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1764 holding.
  • Parkside Financial Bank & Trust first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • Parkside Financial Bank & Trust's Astera Labs position peaked at $14.1K in Q4 2025.
  • 706 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.